Smartno pri Litiji, Slovenia

Anton Copar

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 28(Granted Patents)


Location History:

  • Smartno pri Litiji, SI (1994 - 2011)
  • Smartno pri Ltiji, SI (2011)
  • Smartno pri Litigi, SI (2013)
  • Smartno pri Litijl, SI (2014)
  • Ljubljana, SI (2013 - 2016)

Company Filing History:


Years Active: 1994-2016

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Anton Copar: Innovator in Pharmaceutical Chemistry

Introduction

Anton Copar is a distinguished inventor based in Smartno pri Litiji, Slovenia. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 14 patents. His work primarily focuses on the development of innovative processes for drug preparation.

Latest Patents

Among his latest patents is a process for the preparation of 3-aroyl-5-aminobenzofuran derivatives. This invention is particularly noteworthy as it provides a method for creating compounds useful as antiarrhythmic drugs while avoiding the use of nitro intermediates. Another significant patent involves the preparation of amorphous calcium salt of atorvastatin. This process includes a carefully controlled reaction mixture and the use of specific organic solvents to isolate amorphous atorvastatin calcium effectively.

Career Highlights

Throughout his career, Anton has worked with notable companies such as Lek Pharmaceuticals and Lek, Torvarna Farmacevtskih. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to the advancement of drug development.

Collaborations

Anton has collaborated with esteemed colleagues, including Ljubomir Antoncic and Borut Furlan. These partnerships have further enriched his research and development efforts in the pharmaceutical sector.

Conclusion

Anton Copar's innovative work in pharmaceutical chemistry and his impressive portfolio of patents underscore his role as a key figure in the industry. His contributions continue to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…